Estimate Recalculated Nov 7, 2024 04:47PM EST
Robert J. Weiland does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., and Pacira Pharmaceuticals, Inc..
Robert J. Weiland's CIK is 0001670648
2017 was Robert J. Weiland's most active year for acquiring shares with 5 total transactions. Robert J. Weiland's most active month to acquire stocks was the month of May. 2018 was Robert J. Weiland's most active year for disposing of shares, totalling 1 transactions. Robert J. Weiland's most active month to dispose stocks was the month of May. 2016 saw Robert J. Weiland paying a total of $0.00 for 84,000 shares, this is the most they've acquired in one year. In 2018 Robert J. Weiland cashed out on 373 shares for a total of $12,316.46, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!